Spontaneous bleeding and poor bleeding response with extended half-life factor IX products: A survey of select US haemophilia treatment centres

Haemophilia. 2020 May;26(3):e128-e129. doi: 10.1111/hae.13943. Epub 2020 Mar 6.

Authors

Lynn M Malec^{1

2}, Stacy E Croteau³, Michael U Callaghan⁴, Robert F Sidonio Jr⁵

Affiliations

¹ Versiti Blood Research Institute, Milwaukee, Wisconsin.
² Medical College of Wisconsin, Milwaukee, Wisconsin.
³ Children's Hospital of Boston, Boston, Massachusetts.
⁴ Children's Hospital of Michigan, Detroit, Michigan.
⁵ Children's Healthcare of Atlanta, Atlanta, Georgia.

PMID: 32142196
DOI: 10.1111/hae.13943

No abstract available

Publication types

Letter

MeSH terms

Factor IX / adverse effects*
Half-Life
Hemorrhage / etiology*
Hemorrhage / pathology
Humans
Surveys and Questionnaires
United States

Substances

Factor IX